Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma
RAF/MEK/ERK 和 IGF1R/AKT/mTOR 抑制对神经母细胞瘤的临床前治疗效果
期刊:Cancers
影响因子:
doi:10.3390/cancers16132320
Stacey Stauffer, Jacob S Roth, Edjay R Hernandez, Joshua T Kowalczyk, Nancy E Sealover, Katie E Hebron, Amy James, Kristine A Isanogle, Lisa A Riffle, Lilia Ileva, Xiaoling Luo, Jin-Qiu Chen, Noemi Kedei, Robert L Kortum, Haiyan Lei, Jack F Shern, Joseph D Kalen, Elijah F Edmondson, Matthew D Hall,
信号转导
神经
其它细胞
IP
WB
MAPK/ERK
PI3K/Akt
mTOR
NF1